0001842952-23-000062.txt : 20230531 0001842952-23-000062.hdr.sgml : 20230531 20230531165347 ACCESSION NUMBER: 0001842952-23-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kantoff Philip W. CENTRAL INDEX KEY: 0001866025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40654 FILM NUMBER: 23981757 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863738787 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 4 1 wf-form4_168556641370866.xml FORM 4 X0407 4 2023-05-31 0 0001842952 Context Therapeutics Inc. CNTX 0001866025 Kantoff Philip W. 2001 MARKET STREET SUITE 3915, UNIT #15 PHILADELPHIA PA 19103 1 0 0 0 0 Stock Option (right to buy) 0.87 2023-05-31 4 A 0 25000 0 A 2033-05-30 Common Stock 25000.0 25000 D The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer. /s/ Alex Levit, Attorney-in-Fact 2023-05-31